journal article·2000-02

Clinical investigation of the role of membrane structure on blood contact and solute transport characteristics of a cellulose membrane

N.A Hoenich, S Stamp

Biomaterials· Volume 21· Issue 3
Publisher page

Abstract

Regenerated cellulose membranes contain cellulose chains with crystalline and amorphous regions in the direction of extrusion. A study was undertaken to investigate if reduced contact surface arising from alteration of pore size alters biocompatibility (complement activation (C3a and C5a) and neutropenia) and solute transport. The average pore size for the membrane studied (RC HP400A) was 7.23 compared to 2.76 nm for the standard membrane (Cuprophan). C3a levels rose to 6861+/-1595 compared to 2723+/-1228 ng/ml for Cuprophan at 15 min after initial blood contact (P < 0.0001). C5a levels also rose to 30.1+/-11.9 compared to 21.3+/-6.6 ng/ml for Cuprophan (P = 0.18). Both fractions gradually returned to baseline levels thereafter. Circulating white cell count fell rapidly over the same time period to 39+/-17% of the baseline value by 15 min and was similar to Cuprophan (27.5+/-11.2%) (P = 0.25). A small (< 10%) change in platelet numbers was noted for both membranes. Removal of urea (60 Da) was independent of pore size; however, the RC HP400A removed r2 microglobulin (11818 Da). These findings indicate that pore distribution fails to influence material-induced complement activation but influences large solute transport.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Dialysis and Renal Disease Management · Central Venous Catheters and Hemodialysis · Platelet Disorders and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (20)

Show source-provided references
1. β2-microglobulin amyloidosis10.1046/j.1525-1594.1998.06209.x ↗
2. Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits10.1016/0267-6605(93)90017-2 ↗
3. Biocompatibility in haemodialysis10.1097/00041552-199711000-00005 ↗
5. Regenerated cellulose microporous membranes by mixing cellulose cuoxam with a water soluble polymer10.1016/0376-7388(95)00314-2 ↗
6. Structural analysis of hemodialysis membranes by evaluating distribution volume of water contained in the membranes10.1006/jcis.1995.1191 ↗
7. Synthetically modified cellulose10.1016/S0142-9612(97)00062-8 ↗
8. Application of a standard method to characterise clearance blood flow relationships in hemodialysis10.1111/j.1525-1594.1995.tb02275.x ↗
9. No change in corrected β2 microglobulin concentration after cuprophane dialysis10.1016/S0140-6736(87)90266-2 ↗
10. Complement activation on artificial surfaces in biomedical therapies
11. Complement activation during hemodialysis10.1111/j.1525-1594.1984.tb04291.x ↗
12. Cellulose based haemodialysis membranes10.1093/oxfordjournals.ndt.a092139 ↗
13. Enhanced biocompatibility with a new cellulosic membrane—Cuprophan versus Hemophan10.1159/000169475 ↗
14. Bosch T, Schmidt B, Samtleben W, Gurland HJ. Biocompatibility and clinical performance of a new modified cellulose membrane. Clin Nephrol 1986;26(Suppl 1):S22–9.
15. Individual differences in biocompatibility responses to hemodialysis10.1177/039139889401701003 ↗
16. Improvement of dialyzer biocompatibility by reduction of membrane surface area
17. Increased amounts of C3a and the terminal complement complex at high dialysis blood flow10.1159/000188933 ↗
18. Three dimensional structure of β2 microglobulin10.1073/pnas.82.12.4225 ↗
19. A comparison of dialysers with low-flux membranes10.1093/ndt/12.5.965 ↗
20. β2 microglobulin kinetics during hemodialysis and hemofiltration